GURUFOCUS.COM » STOCK LIST » Canada » NEOE » Mydecine Innovations Group Inc (NEOE:MYCO) » Definitions » Securities & Investments
Switch to:

Mydecine Innovations Group (NEOE:MYCO) Securities & Investments

View and export this data going back to 2014. Start your Free Trial

Securities & Investments only applies to banks.

Mydecine Innovations Group (NEOE:MYCO) Business Description

Mydecine Innovations Group logo
Traded in Other Exchanges
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.